ABL DIAGNOSTICS (EPA:ABLD) | WebDisclosure

Basculer en Français

11272	Companies
250427	Keywords
179003	Articles
136273	Press releases

Home
Companies
ABL DIAGNOSTICS

PRESS RELEASE

published on 06/12/2026 at 08:00, 4 months 22 days ago

Informations privilégiées / Autres communiqués
ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel de 2,7 M€ jusqu'en 2031 avec un laboratoire pharmaceutique européen, renforçant ainsi leurs activités dans les services à valeur ajoutée liés à la recherche clinique internationale

Recherche Clinique Maladies Neurodégénératives Contrat International ABL Diagnostics CDL Pharma
PRESS RELEASE

published on 06/12/2026 at 08:00, 4 months 22 days ago

Inside Information / Other news releases
ABL Diagnostics and CDL Pharma secure a multi-year international contract of up to €2.7 million through 2031. The contract involves services for neurodegenerative disease clinical programs across North America, Europe, and Asia

Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma International Clinical Program
BRIEF

published on 06/10/2026 at 00:05, 4 months 24 days ago

ABL Diagnostics : Informations sur les droits de vote et le capital

Euronext Paris Droits De Vote Actions Nominatives Biologie Moléculaire Capital Social ABL
BRIEF

published on 06/10/2026 at 00:05, 4 months 24 days ago

ABL Diagnostics Discloses Voting and Share Information

Euronext Paris Share Capital Voting Rights Molecular Biology Double Voting
BRIEF

published on 06/10/2026 at 00:05, 4 months 24 days ago

ABL Diagnostics: Information on voting rights and capital

Euronext Paris Voting Rights Registered Shares Molecular Biology ABL Share Capital
BRIEF

published on 06/10/2026 at 00:05, 4 months 24 days ago

ABL Diagnostics divulgue des informations sur le vote et les actions

Euronext Paris Capital Social Droit De Vote Biologie Moléculaire Double Vote
PRESS RELEASE

published on 06/10/2026 at 00:00, 4 months 24 days ago

Modalités de mise à disposition des documents préparatoires à l'AG
ABL Diagnostics (ABLD) est une société internationale spécialisée dans les tests de biologie moléculaire innovants. Son siège est à Woippy. Elle est cotée sur Euronext Paris

Euronext Paris Biologie Moléculaire ABL Diagnostics Innovants Woippy
PRESS RELEASE

published on 06/10/2026 at 00:00, 4 months 24 days ago

Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers

Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
BRIEF

published on 06/09/2026 at 19:05, 4 months 24 days ago

ABL Diagnostics annonce la tenue de son assemblée générale le 30 juin 2026.

Actionnaires Paris Assemblée Générale États Financiers Diagnostics ABL
BRIEF

published on 06/09/2026 at 19:05, 4 months 24 days ago

ABL Diagnostics is preparing for its General Assembly on June 30, 2026

Investors General Assembly Preparatory Documents Molecular Biology ABL Diagnostics

Accesswire

Published on 11/04/2026 at 00:05, 9 hours 30 minutes ago

Scoping Study Begins for High-Grade Underground Mine Feed
Published on 11/04/2026 at 00:00, 9 hours 35 minutes ago

RE Royalties Launches $5 Million Series 5 Green Bond Offering and Provides Strategic Growth Update
Published on 11/03/2026 at 23:30, 10 hours 5 minutes ago

AT&T and Amdocs Expand Collaboration, Bringing Together Amdocs aOS and AT&T's AI-Enabled Framework to Simplify Operations and Improve Customer Experiences
Published on 11/03/2026 at 23:30, 10 hours 5 minutes ago

GGL Resources Corp. Issues Post-Consolidation Shares to Strategic Metals Ltd.
Published on 11/03/2026 at 23:15, 10 hours 20 minutes ago

Petrolympic Announces Option Grant

View all ACCESSWIRE

EQS Group

Published on 11/04/2026 at 09:15, 19 minutes ago

Fox ESS Signs Youngest Porsche Carrera Cup Germany Winner, Champion On and Off the Track
Published on 11/04/2026 at 09:15, 19 minutes ago

Omnissa expands Sovereign Solution to more markets, designed to give enterprises a safe place to run AI
Published on 11/04/2026 at 09:05, 29 minutes ago

New global Mouth-to-Body Health Institute aims to turn oral-systemic science into better prevention and care
Published on 11/04/2026 at 09:00, 34 minutes ago

Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 11/04/2026 at 09:00, 34 minutes ago

Original-Research: CEOTRONICS AG (von NuWays AG): BUY

Les Echos

Published on 11/04/2026 at 09:21, 13 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 11/03/2026 at 18:39, 14 hours 56 minutes ago

NRJ Group - Information relative aux droits de vote au 31.10.2026 (French & English)
Published on 11/03/2026 at 18:00, 15 hours 35 minutes ago

Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 18:00, 15 hours 35 minutes ago

Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote - 31 octobre 2026
Published on 11/03/2026 at 17:45, 15 hours 50 minutes ago

Declaration of voting rights at the end of October 2026

View all LES ECHOS COMFI WIRE